Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-1 Infection”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Early research (Phase 1)Study completedNCT05548439
What this trial is testing

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Who this might be right for
COVID-19Coronavirus Infections
VBI Vaccines Inc. 103
Not applicableStudy completedNCT05787405
What this trial is testing

Early Diagnosis of Clinical Evolution From SARS-CoV-2

Who this might be right for
SARS-CoV-1 Infection
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 8,000
Post-approval studies (Phase 4)Study completedNCT05711810
What this trial is testing

Medicine-induced Cardiac Hemodialysis on COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome-related CoronavirusRenal DialysisVaccines+2 more
Yang I. Pachankis 1
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Not applicableUnknownNCT06047067
What this trial is testing

Bioaerosol Sampling Device (BSD) Clinical Study

Who this might be right for
COVID-19
Cantor BioConnect, Inc. 330
Early research (Phase 1)WithdrawnNCT05614245
What this trial is testing

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

Who this might be right for
COVID-19Coronavirus Infections
VBI Vaccines Inc.
Testing effectiveness (Phase 2)Study completedNCT04343261
What this trial is testing

Convalescent Plasma in the Treatment of COVID 19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVIDCoronavirus
Trinity Health Of New England 48